HPV and cervical cancer: screening or vaccination?
Br J Cancer
; 98(1): 15-21, 2008 Jan 15.
Article
en En
| MEDLINE
| ID: mdl-18182975
ABSTRACT
Following the demonstration of the superior validity of human papillomavirus (HPV) tests in screening for cervical cancer and the arrival of highly efficacious HPV 16 and 18 vaccines, cervical cancer prevention enters a time of sustainable introduction in developing countries. Multidisciplinary efforts and novel protocols are being developed, and challenging situations are being faced to make cervical cancer, still the number two cancer in women worldwide, an eradicable condition.
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Neoplasias del Cuello Uterino
/
Infecciones por Papillomavirus
/
Vacunas contra Papillomavirus
Tipo de estudio:
Diagnostic_studies
/
Screening_studies
Límite:
Female
/
Humans
Idioma:
En
Revista:
Br J Cancer
Año:
2008
Tipo del documento:
Article
País de afiliación:
España